ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity

被引:285
作者
Colicelli, John [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Inst Mol Biol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
关键词
CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; GROWTH-FACTOR RECEPTOR; ACTIN-BINDING DOMAINS; SRC FAMILY KINASES; C-ABL; BCR-ABL; F-ACTIN; V-ABL;
D O I
10.1126/scisignal.3139re6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
ABL-family proteins comprise one of the best conserved branches of the tyrosine kinases. Each ABL protein contains an SH3-SH2-TK (Src homology 3-Src homology 2-tyrosine kinase) domain cassette, which confers autoregulated kinase activity and is common among nonreceptor tyrosine kinases. This cassette is coupled to an actin-binding and -bundling domain, which makes ABL proteins capable of connecting phosphoregulation with actin-filament reorganization. Two vertebrate paralogs, ABL1 and ABL2, have evolved to perform specialized functions. ABL1 includes nuclear localization signals and a DNA binding domain through which it mediates DNA damage-repair functions, whereas ABL2 has additional binding capacity for actin and for microtubules to enhance its cytoskeletal remodeling functions. Several types of posttranslational modifications control ABL catalytic activity, subcellular localization, and stability, with consequences for both cytoplasmic and nuclear ABL functions. Binding partners provide additional regulation of ABL catalytic activity, substrate specificity, and downstream signaling. Information on ABL regulatory mechanisms is being mined to provide new therapeutic strategies against hematopoietic malignancies caused by BCR-ABL1 and related leukemogenic proteins.
引用
收藏
页数:26
相关论文
共 246 条
[1]
ABELSON HT, 1970, CANCER RES, V30, P2213
[2]
Allosteric inhibitors of Bcr-abl-dependent cell proliferation [J].
Adrián, FJ ;
Ding, Q ;
Sim, TB ;
Velentza, A ;
Sloan, C ;
Liu, Y ;
Zhang, GB ;
Hur, W ;
Ding, S ;
Manley, P ;
Mestan, J ;
Fabbro, D ;
Gray, NS .
NATURE CHEMICAL BIOLOGY, 2006, 2 (02) :95-102
[3]
Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1 [J].
Afar, DEH ;
Han, LM ;
McLaughlin, J ;
Wong, S ;
Dhaka, A ;
Parmar, K ;
Rosenberg, N ;
Witte, ON ;
Colicelli, J .
IMMUNITY, 1997, 6 (06) :773-782
[4]
An activating mutation in the ATP binding site of the ABL kinase domain [J].
Allen, PB ;
Wiedemann, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19585-19591
[5]
Andoniou CE, 1996, ONCOGENE, V12, P1981
[6]
A crucial role in cell spreading for the interaction of Abl PxxP motifs with Crk and Nck adaptors [J].
Antoku, Susumu ;
Saksela, Kalle ;
Rivera, Gonzalo M. ;
Mayer, Bruce J. .
JOURNAL OF CELL SCIENCE, 2008, 121 (18) :3071-3082
[7]
Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL [J].
Azam, M ;
Latek, RR ;
Daley, GQ .
CELL, 2003, 112 (06) :831-843
[8]
Emerging roles of Abl family tyrosine kinases in microbial pathogenesis [J].
Backert, Steffen ;
Feller, Stephan M. ;
Wessler, Silja .
TRENDS IN BIOCHEMICAL SCIENCES, 2008, 33 (02) :80-90
[9]
PHD fingers in human diseases: Disorders arising from misinterpreting epigenetic marks [J].
Baker, Lindsey A. ;
Allis, C. David ;
Wang, Gang G. .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2008, 647 (1-2) :3-12
[10]
An intramolecular SH3-domain interaction regulates c-Abl activity [J].
Barilá, D ;
Superti-Furga, G .
NATURE GENETICS, 1998, 18 (03) :280-282